Bottom line
JAFMX vs SWHFX: the short answer
JAFMX (Health Sciences Trust) and SWHFX (Schwab Health Care Fund) are both mutual funds.
But JAFMX is far broader, holding 173 positions to 80 for SWHFX, so beyond the top names it adds exposure SWHFX doesn't have.
SWHFX is cheaper at 0.8% vs 0.99% — a difference of $19 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +4.2% for JAFMX.
Updated Nov 19, 2026
JAFMX vs SWHFX side by side
| JAFMX | SWHFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | John Hancock | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.99% | 0.8% |
| Annual cost per $10k | $99 | $80 |
| 10-yr cost on $10k (prospectus) | $1,224 | $990 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +19.5% | +15.9% |
| 5-yr return (annualized) | +4.2% | +6.5% |
| 10-yr return (annualized) | +8.8% | +8.1% |
| Best quarter | — | +15.3% |
| Worst quarter | — | −12.1% |
| Net assets (fund) | $251.3M | $642.3M |
| Number of holdings | 173 | 80 |
| Portfolio turnover | 68% | 41% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of JAFMX's top 25 holdings also appear in SWHFX's top 25.
| Holding | JAFMX | SWHFX |
|---|---|---|
| Eli Lilly and Company | 14.30% | 13.92% |
| Johnson and Johnson | 6.33% | 6.94% |
| UnitedHealth Group Incorporated | 5.95% | 4.74% |
| AbbVie Inc. | 5.28% | 5.81% |
| Merck and Co. Inc. | 4.21% | 4.98% |
| Gilead Sciences Inc. | 2.95% | 3.24% |
| Thermo Fisher Scientific Inc. | 2.67% | 2.16% |
| Vertex Pharmaceuticals Incorporated | 2.38% | 1.89% |
| Bristol-Myers Squibb Company | 2.22% | 2.44% |
| Abbott Laboratories | 2.00% | 1.60% |
| Amgen Inc. | 1.90% | 2.58% |
| Stryker Corporation | 1.87% | 2.11% |
| Elevance Health Inc. | 1.63% | 1.45% |
| Danaher Corporation | 1.51% | 1.47% |
Source: SEC Form N-PORT
JAFMX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between JAFMX and SWHFX?
Which is cheaper, JAFMX or SWHFX?
Should I own both JAFMX and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.